ND

Nirmala Devi

Active Director Director DIN 10322763
DIN 10322763 First appointment Sep 2023 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value •••• Premium profile

About Nirmala Devi

Data last updated:

Nirmala Devi is a Director at Promed Biotech Private Limited (since 2023). The company operates in Trading. Promed Biotech Private Limited reported revenue of ₹5.8 Lakh (FY 2025).

DIN 10322763
Primary Designation Director
Industry Trading
First Appointment 13 Sep 2023
Oldest Company Age 5 yrs
Largest company Promed Biotech Private Limited · ₹5.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Promed Biotech Private Limited U51909GJ2021PTC126799
Director13 Sep 20232021₹5.8 Lakh (FY 2025)Active

Board colleagues of Nirmala Devi

NameDINCompanyDesignation
Ranjeet Kumar10322806Promed Biotech Private LimitedDirector
Vanshbahadur09377937Promed Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Promed Biotech Private Limited
Premium access

Shareholding and investment profile for Nirmala Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nirmala Devi

Nirmala Devi currently holds 1 directorship: Promed Biotech Private Limited (Director, since 13 Sep 2023, revenue ₹5.8 Lakh (FY 2025)).

Nirmala Devi was first appointed on 13 Sep 2023 as Director at Promed Biotech Private Limited.

The current boards of Nirmala Devi's companies include Ranjeet Kumar (Promed Biotech Private Limited), Vanshbahadur (Promed Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available